STAT1 Gain-of-Function Mutation in Chronic Mucocutaneous Candidiasis

被引：0
|
作者：
Antoniadi, Marita [1 ]
Tzanoudaki, Marianna [2 ]
Karkanis, Vaggelis [1 ]
Kostaridou, Stavroula [1 ]
Tsagris, Vasileios [1 ]
机构：
[1] Penteli Childrens Hosp, Dept Pediat, Athens, Greece
[2] Agia Sophia Childrens Hosp, Lab Immunol & Histocompatibil, Athens, Greece
来源：
INDIAN JOURNAL OF PEDIATRICS | 2024年 / 91卷 / 12期
关键词：
UNDERLIE;
D O I：
10.1007/s12098-024-05248-1
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1312 / 1312
页数：1
相关论文
共 50 条
  • [41] Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation
    Lu, Xiaodi
    Zhang, Keming
    Jiang, Weiwei
    Li, Hang
    Huang, Yue
    Du, Mingwei
    Wan, Jian
    Cao, Yanyun
    Du, Lin
    Liu, Xiaogang
    Pan, Weihua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Chronic mucocutaneous candidiasis due to signal transducer and activator of transcription 1 (STAT 1) mutation in an indian patient - A case report
    Balasundaram, Abyramy
    George, Renu
    Abraham, Aby
    Michael, Joy S.
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2022, 13 (01) : 90 - 93
  • [43] Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib
    Dotta, Laura
    Todaro, Francesca
    Baronio, Manuela
    Giacomelli, Mauro
    Pinelli, Marinella
    Giambarda, Martina
    Brognoli, Beatrice
    Greco, Silvia
    Rota, Francesca
    Cortesi, Manuela
    Soresina, Annarosa
    Moratto, Daniele
    Tomasi, Cesare
    Ferraro, Rosalba Monica
    Giliani, Silvia
    Badolato, Raffaele
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (04)
  • [44] Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression
    Ovadia, Adi
    Sharfe, Nigel
    Hawkins, Cynthia
    Laughlin, Suzanne
    Roifman, Chaim M.
    NPJ GENOMIC MEDICINE, 2018, 3
  • [45] A 3-Year-Old Girl with Recurrent Infections and Autoimmunity due to a STAT1 Gain-of-Function Mutation: The Expanding Clinical Presentation of Primary Immunodeficiencies
    Aldave Becerra, Juan Carlos
    Cachay Rojas, Enrique
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [46] Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
    Tabellini, Giovanna
    Vairo, Donatella
    Scomodon, Omar
    Tamassia, Nicola
    Ferraro, Rosalba Monica
    Patrizi, Ornella
    Gasperini, Sara
    Soresina, Annarosa
    Giardino, Giuliana
    Pignata, Claudio
    Lougaris, Vassilios
    Plebani, Alessandro
    Dotta, Laura
    Cassatella, Marco A.
    Parolini, Silvia
    Badolato, Raffaele
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (02) : 553 - +
  • [47] DNA-Binding domain mutations confer severe outcome at an early age among STAT1 gain-of-function patients
    Scott, Ori
    Dadi, Harjit
    Vong, Linda
    Pasternak, Yehonatan
    Garkaby, Jenny
    Pachul, Jessica Willett
    Mandola, Amarilla B.
    Brager, Rae
    Hostoffer, Robert
    Nahum, Amit
    Roifman, Chaim M.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 (01)
  • [48] STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition
    Chaimowitz, Natalia S.
    Anderson, Mark
    Forbes, Lisa R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1494 - 1496
  • [49] STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders
    Olbrich, Peter
    Freeman, Alexandra F.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (06) : 440 - 447
  • [50] STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC
    Hiller, Julia
    Hagl, Beate
    Effner, Renate
    Puel, Anne
    Schaller, Martin
    Mascher, Birgit
    Eyerich, Stefanie
    Eyerich, Kilian
    Jansson, Annette F.
    Ring, Johannes
    Casanova, Jean-Laurent
    Renner, Ellen D.
    Traidl-Hoffmann, Claudia
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (03) : 711 - 714
12345